Page last updated: 2024-11-01

nortriptyline and Angiomatosis Oculoorbital-Thalamic Syndrome

nortriptyline has been researched along with Angiomatosis Oculoorbital-Thalamic Syndrome in 1 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fjær, R1
Marciniak, K1
Sundnes, O1
Hjorthaug, H1
Sheng, Y1
Hammarström, C1
Sitek, JC1
Vigeland, MD1
Backe, PH1
Øye, AM1
Fosse, JH1
Stav-Noraas, TE1
Uchiyama, Y1
Matsumoto, N1
Comi, A1
Pevsner, J1
Haraldsen, G1
Selmer, KK1

Other Studies

1 other study available for nortriptyline and Angiomatosis Oculoorbital-Thalamic Syndrome

ArticleYear
A novel somatic mutation in GNB2 provides new insights to the pathogenesis of Sturge-Weber syndrome.
    Human molecular genetics, 2021, 10-13, Volume: 30, Issue:21

    Topics: Adolescent; Adult; Child; DNA Mutational Analysis; Exome Sequencing; Gene Frequency; Genetic Associa

2021